Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity
British journal of surgery2009Vol. 97(2), pp. 160–166
Citations Over TimeTop 10% of 2009 papers
Torgeir T. Søvik, OM Taha, Erlend T. Aasheim, My Engström, Jon Kristinsson, Sofia Björkman, Carl Fredrik Schou, Hans Lönroth, Tom Mala, Torsten Olbers
Abstract
LRYGB and LDS can be performed with comparable perioperative safety in superobese patients. LDS provides greater weight loss in the first year.
Related Papers
- → Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients(2012)60 cited
- → P-31 Weight loss is more sustained after biliopancreatic diversion with duodenal switch than Roux-en-Y gastric bypass in superobese patients(2011)2 cited
- → A Matched Cohort Comparison of Laparoscopic Biliopancreatic Diversion With Duodenal Switch and Roux-En-Y Gastric Bypass(2015)1 cited
- → Comment on: Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity—weight loss versus side effects(2010)
- → A055 Conversion of Roux-en-Y Gastric Bypass to Biliopancreatic Diversion with Duodenal Switch is a Safe and Reliable Method to Achieve Significant Weight Loss(2023)